Correlation Between Teva Pharma and TQM PORATION

Can any of the company-specific risk be diversified away by investing in both Teva Pharma and TQM PORATION at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and TQM PORATION into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Teva Pharma Industries and TQM PORATION, you can compare the effects of market volatilities on Teva Pharma and TQM PORATION and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of TQM PORATION. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and TQM PORATION.

Diversification Opportunities for Teva Pharma and TQM PORATION

0.6

Correlation Coefficient

Teva Pharma  TQM PORATION

Poor diversification

The 3 months correlation between Teva and TQM is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and TQM PORATION in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TQM PORATION and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with TQM PORATION. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TQM PORATION has no effect on the direction of Teva Pharma i.e., Teva Pharma and TQM PORATION go up and down completely randomly.

Pair Corralation between Teva Pharma and TQM PORATION

Given the investment horizon of 90 days Teva Pharma Industries is expected to under-perform the TQM PORATION. In addition to that, Teva Pharma is 5.34 times more volatile than TQM PORATION. It trades about -0.24 of its total potential returns per unit of risk. TQM PORATION is currently generating about -0.24 per unit of volatility. If you would invest  2,583  in TQM PORATION on January 26, 2024 and sell it today you would lose (33.00) from holding TQM PORATION or give up 1.28% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	85.71%
Values	Daily Returns

Teva Pharma Industries  vs.  TQM PORATION

Teva Pharma Industries

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharma Industries are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Teva Pharma may actually be approaching a critical reversion point that can send shares even higher in May 2024.

TQM PORATION

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in TQM PORATION are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, TQM PORATION is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Teva Pharma and TQM PORATION

The main advantage of trading using opposite Teva Pharma and TQM PORATION positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, TQM PORATION can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TQM PORATION will offset losses from the drop in TQM PORATION's long position.

The idea behind Teva Pharma Industries and TQM PORATION pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.